Buscar
Mostrando publicaciones 1-6 de 6
Dietary advanced glycation end products and their role in health and disease
(2015)
Over the past 2 decades there has been increasing evidence supporting an important contribution from food-derived advanced glycation end products (AGEs) to the body pool of AGEs and therefore increased oxidative stress and ...
The potential role of dietary advanced glycation endproducts in the development of chronic non-infectious diseases: A narrative review
(2020)
Increasing clinical and experimental evidence accumulated during the past few decades supports an important role for dietary advanced glycation endproducts (AGE) in the pathogenesis of many chronic non-infectious diseases, ...
Contribution of RAGE axis activation to the association between metabolic syndrome and cancer
(2021)
Far beyond the compelling proofs supporting that the metabolic syndrome represents a risk factor for diabetes and cardiovascular diseases, a growing body of evidence suggests that it is also a risk factor for different ...
Dietary AGEs as exogenous boosters of inflammation
(2021)
Most chronic modern non-transmissible diseases seem to begin as the result of low-grade inflammation extending over prolonged periods of time. The importance of diet as a source of many pro-inflammatory compounds that could ...
Association of receptor for advanced glycation end product (RAGE) gene polymorphisms and serum levels of soluble RAGE (sRAGE) with metabolic syndrome (MS) in mexican population
(2020)
Background. RAGE, a multi-ligand transmembrane glycoprotein transduces biological signals associated with chronic cellular stress, and chronic and degenerative diseases. sRAGE is a variant of RAGE derived from cell surface ...
Polymorphisms −374 T/A and −429 T/C of the receptor for advanced glycation end-products (RAGE) and serum levels of RAGE (sRAGE) are not associated with metabolic syndrome
(2023)
RAGE is a multi-ligand transmembrane glycoprotein that promotes biological signals associated with inflammatory responses and degenerative diseases. sRAGE is a soluble variant that has been proposed as an inhibitor of RAGE ...